000			01943 a2200541 4500
005			20250515023253.0
264		0	_c20060718
008			200607s 0 0 eng d
022			_a1524-4636
024	7		_a10.1161/01.ATV.0000222908.78873.36 _2doi
040			_aNLM _beng _cNLM
100	1		_aMälarstig, Anders
245	0	0	_aSoluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome. _h[electronic resource]
260			_bArteriosclerosis, thrombosis, and vascular biology _cJul 2006
300			_a1667-73 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAcute Disease
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aBase Sequence
650	0	4	_aBiomarkers _xblood
650	0	4	_aCD40 Ligand _xblood
650	0	4	_aCoronary Disease _xblood
650	0	4	_aDalteparin _xtherapeutic use
650	0	4	_aElectrocardiography
650	0	4	_aFemale
650	0	4	_aFibrinolytic Agents _xtherapeutic use
650	0	4	_aGenetic Variation
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyocardial Infarction _xetiology
650	0	4	_aOsmolar Concentration
650	0	4	_aPolymorphism, Genetic
650	0	4	_aPolymorphism, Single Nucleotide
650	0	4	_aPrognosis
650	0	4	_aSolubility
650	0	4	_aSurvival Analysis
650	0	4	_aSyndrome
650	0	4	_aTreatment Outcome
650	0	4	_aTroponin T _xblood
700	1		_aLindahl, Bertil
700	1		_aWallentin, Lars
700	1		_aSiegbahn, Agneta
773	0		_tArteriosclerosis, thrombosis, and vascular biology _gvol. 26 _gno. 7 _gp. 1667-73
856	4	0	_uhttps://doi.org/10.1161/01.ATV.0000222908.78873.36 _zAvailable from publisher's website
999			_c16231951 _d16231951